Publication: Stroke
dc.contributor.coauthor | N/A | |
dc.contributor.department | N/A | |
dc.contributor.kuauthor | Çakmak, Özgür Öztop | |
dc.contributor.kuauthor | Vanlı-Yavuz, Ebru Nur | |
dc.contributor.kuauthor | Özdemir, Yasemin Gürsoy | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.kuprofile | Doctor | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.researchcenter | Koç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM) | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.unit | N/A | |
dc.contributor.unit | Koç University Hospital | |
dc.contributor.unit | N/A | |
dc.contributor.yokid | 299358 | |
dc.contributor.yokid | 251177 | |
dc.contributor.yokid | 170592 | |
dc.date.accessioned | 2024-11-09T23:50:19Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Stroke is a devastating neurological disease with a few therapeutic approaches. Despite the acute and prophylactic treatment options, novel effective treatments are required. The main limitation for effective treatment strategies to be developed is the presence of the blood–brain barrier. Targeted nanoparticulate treatment options may help to overcome this issue. This chapter deals with novel studies performed for targeted drug delivery technologies for stroke. | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.openaccess | NO | |
dc.description.publisherscope | International | |
dc.identifier.doi | 10.1016/B978-0-12-803796-6.00014-9 | |
dc.identifier.eissn | N/A | |
dc.identifier.isbn | 978-0-12-803800-0 | |
dc.identifier.isbn | 978-0-12-803796-6 | |
dc.identifier.issn | N/A | |
dc.identifier.quartile | N/A | |
dc.identifier.scopus | 2-s2.0-85032159539 | |
dc.identifier.uri | http://dx.doi.org/10.1016/B978-0-12-803796-6.00014-9 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/14526 | |
dc.identifier.wos | 449489600015 | |
dc.keywords | Blood-brain-barrier | |
dc.keywords | Drug-delivery | |
dc.keywords | Nanoparticles BLOOD-BRAIN-BARRIER | |
dc.keywords | DRUG-DELIVERY | |
dc.keywords | NANOPARTICLES | |
dc.keywords | RECOMMENDATIONS | |
dc.keywords | ISCHEMIA | |
dc.keywords | BURDEN | |
dc.keywords | INJURY | |
dc.language | English | |
dc.publisher | Academic Press Inc Elsevier Science | |
dc.source | Nanotechnology Methods for Neurological Diseases and Brain Tumors: Drug Delivery Across The Blood-Brain Barrier | |
dc.subject | Nanoscience | |
dc.subject | Nanotechnology | |
dc.subject | Clinical neurology | |
dc.subject | Neurosciences | |
dc.title | Stroke | |
dc.type | Book Chapter | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0003-3413-0332 | |
local.contributor.authorid | 0000-0001-6915-7493 | |
local.contributor.authorid | 0000-0002-0860-8964 | |
local.contributor.kuauthor | Çakmak, Özgür Öztop | |
local.contributor.kuauthor | Vanlı-Yavuz, Ebru Nur | |
local.contributor.kuauthor | Özdemir, Yasemin Gürsoy |